In fibrotic ILD, desaturation recovery post 6MWT is linked to disease progression, baseline disease severity, and transplant-free survival.
A novel recovery index (RI) integrates desaturation degree, recovery time, and supplemental oxygen use, offering prognostic ...
The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic pulmonary fibrosis into its Biomarker Qualification Program, according to a press ...